SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Geoff Page, Lorna Templeton, Sharon Grace, Paul Roberts, Neil McKeganey, Chris Russell, Alison Liebling, Zetta Kougiali, Charlie Lloyd, Conspicuous by their abstinence: The limited engagement of heroin users in English and Welsh Drug Recovery Wings, International Journal of Drug Policy, 2015,

    CrossRef

  2. 2
    Yang Xia, Shaun Seaman, Matthew Hickman, John Macleod, Roy Robertson, Lorraine Copeland, Jim McKenzie, Daniela De Angelis, Factors affecting repeated cessations of injecting drug use and relapses during the entire injecting career among the Edinburgh Addiction Cohort, Drug and Alcohol Dependence, 2015, 151, 76

    CrossRef

  3. 3
    Angela Beattie, Elsa M.R. Marques, Matthew Barber, Rosemary Greenwood, Jennifer Ingram, Rachel Ayres, Jane Neale, Avril Rees, Barbara Coleman, Matthew Hickman, Script in a Day intervention for individuals who are injecting opioids: a feasibility randomized control trial, Journal of Public Health, 2015, fdv161

    CrossRef

  4. You have free access to this content4
    Michael Gossop, The National Treatment Outcomes Research Study (NTORS) and its influence on addiction treatment policy in the United Kingdom, Addiction, 2015, 110,
  5. 5
    Dr Vibeke Asmussen Frank, Dr Bagga Bje, Bagga Bjerge, Karen Duke, Vibeke Asmussen Frank, The shifting roles of medical stakeholders in opioid substitution treatment: a comparison between Denmark and the UK, Drugs and Alcohol Today, 2015, 15, 4, 216

    CrossRef

  6. 6
    Gregory Hatchett, Treatment Guidelines for Clients with Antisocial Personality Disorder, Journal of Mental Health Counseling, 2015, 37, 1, 15

    CrossRef

  7. 7
    David R. Gastfriend, A pharmaceutical industry perspective on the economics of treatments for alcohol and opioid use disorders, Annals of the New York Academy of Sciences, 2014, 1327, 1
  8. 8
    Tim Millar, Karen P. Hayhurst, Andrew Jones, Matthias Pierce, Linda Davies, Samantha Weston, Graham Dunn, Michael Donmall, Factors associated with receipt of residential rehabilitation by opiate users indicate that these clients are more amenable to drug treatment, Drugs: Education, Prevention and Policy, 2014, 21, 2, 165

    CrossRef

  9. 9
    Robert P. Schwartz, Pierre K. Alexandre, Sharon M. Kelly, Kevin E. O'Grady, Jan Gryczynski, Jerome H. Jaffe, Interim versus standard methadone treatment: A benefit–cost analysis, Journal of Substance Abuse Treatment, 2014, 46, 3, 306

    CrossRef

  10. You have free access to this content10
    Conversation with Christine Godfrey, Addiction, 2013, 108, 2
  11. 11
    David J. Aaron, Early Maladaptive Schemas and Substance Use, Addictive Disorders & Their Treatment, 2013, 12, 4, 193

    CrossRef

  12. 12
    Andrew Osborne, Future delivery of the Drug Interventions Programme: Do the benefits justify the costs?, Journal of Forensic and Legal Medicine, 2013, 20, 7, 816

    CrossRef

  13. 13
    I. Skeie, M. Brekke, T. Clausen, M. Gossop, M. Lindbaek, E. Reinertsen, M. Thoresen, H. Waal, Increased Somatic Morbidity in the First Year after Leaving Opioid Maintenance Treatment: Results from a Norwegian Cohort Study, European Addiction Research, 2013, 19, 4, 194

    CrossRef

  14. 14
    Katherine Payne, Marion McAllister, Linda M. Davies, VALUING THE ECONOMIC BENEFITS OF COMPLEX INTERVENTIONS: WHEN MAXIMISING HEALTH IS NOT SUFFICIENT, Health Economics, 2013, 22, 3
  15. 15
    Anne Bukten, Svetlana Skurtveit, Michael Gossop, Helge Waal, Per Stangeland, Ingrid Havnes, Thomas Clausen, Engagement with opioid maintenance treatment and reductions in crime: a longitudinal national cohort study, Addiction, 2012, 107, 2
  16. 16
    Rebecca McKetin, Jake M. Najman, Amanda L. Baker, Dan I. Lubman, Sharon Dawe, Robert Ali, Nicole K. Lee, Richard P. Mattick, Abdullah Mamun, Evaluating the impact of community-based treatment options on methamphetamine use: findings from the Methamphetamine Treatment Evaluation Study (MATES), Addiction, 2012, 107, 11
  17. 17
    Fabrizio Schifano, Giovanni Martinotti, Anna Cunniff, Volker Reissner, Norbert Scherbaum, Hamid Ghodse, Impact of an 18-Month, NHS-Based, Treatment Exposure for Heroin Dependence: Results from the London Area Treat 2000 Study, The American Journal on Addictions, 2012, 21, 3
  18. 18
    David Schwappach, Svetlana Popova, Satya Mohapatra, Jayadeep Patra, Alexandra Godinho, Jürgen Rehm, Strategies for evaluating the economic value of drugs in alcohol dependence treatment, Drug and Alcohol Dependence, 2012, 122, 3, 165

    CrossRef

  19. 19
    Anders Gustavsson, Mikael Svensson, Frank Jacobi, Christer Allgulander, Jordi Alonso, Ettore Beghi, Richard Dodel, Mattias Ekman, Carlo Faravelli, Laura Fratiglioni, Brenda Gannon, David Hilton Jones, Poul Jennum, Albena Jordanova, Linus Jönsson, Korinna Karampampa, Martin Knapp, Gisela Kobelt, Tobias Kurth, Roselind Lieb, Mattias Linde, Christina Ljungcrantz, Andreas Maercker, Beatrice Melin, Massimo Moscarelli, Amir Musayev, Fiona Norwood, Martin Preisig, Maura Pugliatti, Juergen Rehm, Luis Salvador-Carulla, Brigitte Schlehofer, Roland Simon, Hans-Christoph Steinhausen, Lars Jacob Stovner, Jean-Michel Vallat, Peter Van den Bergh, Jim van Os, Pieter Vos, Weili Xu, Hans-Ulrich Wittchen, Bengt Jönsson, Jes Olesen, Cost of disorders of the brain in Europe 2010, European Neuropsychopharmacology, 2011, 21, 10, 718

    CrossRef

  20. 20
    Charlotte Powell, Marilyn Christie, John Bankart, Deborah Bamber, Ira Unell, Drug treatment outcomes in the criminal justice system: What non-self-report measures of outcome can tell us, Addiction Research & Theory, 2011, 19, 2, 148

    CrossRef

  21. 21
    Keith Humphreys, Todd H. Wagner, Mistry Gage, If substance use disorder treatment more than offsets its costs, why don't more medical centers want to provide it?, Journal of Substance Abuse Treatment, 2011, 41, 3, 243

    CrossRef

  22. 22
    Michelle E. Madden, Steven L. Shapiro, The Methadone Epidemic, The American Journal of Forensic Medicine and Pathology, 2011, 32, 2, 131

    CrossRef

  23. 23
    Louisa Degenhardt, Bradley Mathers, Peter Vickerman, Tim Rhodes, Carl Latkin, Matt Hickman, Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed, The Lancet, 2010, 376, 9737, 285

    CrossRef

  24. 24
    H. Bergsteiner, G. C. Avery, A Generic Multiple Constituency Matrix: Accountability in Private Prisons, Journal of Public Administration Research and Theory, 2009, 19, 3, 631

    CrossRef

  25. 25
    Paul S Haber, Abdullah Demirkol, Kezia Lange, Bridin Murnion, Management of injecting drug users admitted to hospital, The Lancet, 2009, 374, 9697, 1284

    CrossRef

  26. 26
    Thomas Clausen, Helge Waal, Magne Thoresen, Michael Gossop, Mortality among opiate users: opioid maintenance therapy, age and causes of death, Addiction, 2009, 104, 8
  27. 27
    Ana I. Balsa, Jenny F. Homer, Michael T. French, Constance M. Weisner, Substance Use, Education, Employment, and Criminal Activity Outcomes of Adolescents in Outpatient Chemical Dependency Programs, The Journal of Behavioral Health Services & Research, 2009, 36, 1, 75

    CrossRef

  28. 28
    Michael Soyka, David A. Gorelick, Why should addiction medicine be an attractive field for young physicians?, Addiction, 2009, 104, 2
  29. 29
    Christopher M Doran, Economic Evaluation of Interventions to Treat Opiate Dependence, PharmacoEconomics, 2008, 26, 5, 371

    CrossRef

  30. 30
    Maree Teesson, Katherine Mills, Joanne Ross, Shane Darke, Anna Williamson, Alys Havard, The impact of treatment on 3 years' outcome for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS), Addiction, 2008, 103, 1
  31. 31
    Alice Evans, Clean Break drugs and housing project, Housing, Care and Support, 2007, 10, 4, 4

    CrossRef

  32. 32
    Frank Warburton, Debunking the myth of drugs and criminal behaviour, Criminal Justice Matters, 2007, 69, 1, 38

    CrossRef

  33. 33
    Jonathan Cave, Christine Godfrey, Drugs and the Future, 2007,

    CrossRef

  34. 34
    Howard G. Birnbaum, Alan G. White, Jennifer L. Reynolds, Paul E. Greenberg, Mingliang Zhang, Sue Vallow, Jeff R. Schein, Nathaniel P. Katz, Estimated Costs of Prescription Opioid Analgesic Abuse in the United States in 2001, The Clinical Journal of Pain, 2006, 22, 8, 667

    CrossRef

  35. 35
    Christine Godfrey, Evidence-Based Illicit Drug Policy: The Potential Contribution of Economic Evaluation Techniques, De Economist, 2006, 154, 4, 563

    CrossRef

  36. 36
    Peter Reuter, Harold Pollack, How much can treatment reduce national drug problems?, Addiction, 2006, 101, 3
  37. 37
    Ilana B. Crome, Overview: Beyond guidelines and guidance—psychosocial perspectives on treatment interventions for young people with substance problems in the United Kingdom, Drugs: Education, Prevention and Policy, 2006, 13, 3, 203

    CrossRef

  38. 38
    Marian Shanahan, Alys Havard, Maree Teesson, Katherine Mills, Anna Williamson, Joanne Ross, Patterns and costs of treatment for heroin dependence over 12 months: fndings from the Australian Treatment Outcome Study, Australian and New Zealand Journal of Public Health, 2006, 30, 4
  39. 39
    Steven Simoens, Anne Ludbrook, Catriona Matheson, Christine Bond, Pharmaco-economics of community maintenance for opiate dependence: A review of evidence and methodology, Drug and Alcohol Dependence, 2006, 84, 1, 28

    CrossRef

  40. 40
    Shane Darke, Anna Williamson, Joanne Ross, Maree Teesson, Residential Rehabilitation for the Treatment of Heroin Dependence: Sustained Heroin Abstinence and Drug-Related Problems 2 Years After Treatment Entrance, Addictive Disorders & Their Treatment, 2006, 5, 1, 9

    CrossRef

  41. 41
    Jan Keene, A case-linkage study of the relationship between drug misuse, crime, and psychosocial problems in a total criminal justice population, Addiction Research & Theory, 2005, 13, 5, 489

    CrossRef

  42. 42
    Martin Lee, Simon George, Drug Strategy Unit, The British Journal of Forensic Practice, 2005, 7, 4, 39

    CrossRef

  43. 43
    Michael Farrell, Linda Gowing, John Marsden, Walter Ling, Robert Ali, Effectiveness of drug dependence treatment in HIV prevention, International Journal of Drug Policy, 2005, 16, 67

    CrossRef

  44. 44
    Michael Gossop, Katia Trakada, Duncan Stewart, John Witton, Reductions in criminal convictions after addiction treatment: 5-year follow-up, Drug and Alcohol Dependence, 2005, 79, 3, 295

    CrossRef

  45. 45
    Christine Godfrey, Steve Parrott, Gail Eaton, Anthony Culyer, Cynthia McDougall, Substance Use: Individual Behaviour, Social Interactions, Markets and Politics, 2005,

    CrossRef

  46. 46
    John M. Corkery, Fabrizio Schifano, A. Hamid Ghodse, Adenekan Oyefeso, The effects of methadone and its role in fatalities, Human Psychopharmacology: Clinical and Experimental, 2004, 19, 8